Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.

Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients. - Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043368

Enrollment

110

Registered

2021-04-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis, peritoneal dialysis patients/Healthy controls with written informed consent.

Exclusion criteria

Exclusion criteria: Patients who are not likely to survive at least 1 year.

Design outcomes

Primary

Measure	Time frame
Positivity rate of SARS-CoV-2 neutralizing antibody in dialysis patients 12 weeks after vaccination.	—

Secondary

Measure	Time frame
Positivity rate of SARS-CoV-2 neutralizing antibody in dialysis patients before, 3 weeks after the booster and 4th vaccination, and 48 weeks after the last vaccination	—

Countries

Japan

Contacts

Public ContactTakahiro Takazono

Nagasaki University Hospital Department of Respiratory Medicine

takahiro-takazono@nagasaki-u.ac.jp0958197273

Outcome results